Cited by 25Ethics in Clinical ResearchRace, Genetics, and SocietyBiomedical Ethics and Regulation

In Different Voices: The Views of People with Disabilities about Return of Results from Precision Medicine Research

Open access
Sabatello, Maya, Zhang, Yuan, Chen, Ying, Appelbaum, Paul S.·2020·Public Health Genomics

Abstract

Purpose: Returning genetic results to research participants is gaining momentum in the USA. It is believed to be an important step in exploring the impact of efforts to translate findings from research to bedside and public health benefits. Some also hope that this practice will incentivize research participation, especially among people from historically marginalized communities who are commonly underrepresented in research. However, research participants’ interest in receiving nongenomic medical and nonmedical results that may emerge from precision medicine research (PMR) is understudied and no study to date has explored the views of people with disabilities about return of genomic and nongenomic results from PMR. Methods: In a national online survey of people with disabilities, participants were queried about their interest in receiving biological, environmental, and lifestyle results from PMR (n = 1,294). Analyses describe findings for all of the participants and comparisons for key demographic characteristics and disability subgroups. Results: The participants expressed high interest in biological and health-related results and less interest in other findings. However, the interest among the study participants was lower than that found in comparable studies of the general population. Moreover, this interest varied significantly across gender, race/ethnicity, and disability subgroups. Possible reasons for these differences are discussed. Conclusion: Insofar as return of results from PMR may impact translational efforts, it is important to better understand the role of sociomedical marginalization in decisions about return of results from PMR and to develop strategies to address existing barriers.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000506599

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several quantitative studies indicate that patients want to be fully informed about tests, the results and treatment options.

    “Several quantitative studies indicate that patients want to be fully informed about tests [71], the results [51, 71, 72, 78] and treatment options [29].”

    From Patients’ and professionals’ views related to ethical issues in precision medicine: a mixed research synthesis (2021) · cites this paper as [78]

    The Results (‘Overall Interest in Results from PMR’; page not provided) report that most participants wanted their genetic results (78%), but interest varied substantially by result type. The study surveyed people with disabilities about results from precision medicine research; it does not establish that patients generally want to be fully informed about all results. This citation is attached to ‘the results,’ not to tests or treatment options. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 46

  1. [1]Parens E, Appelbaum PS: Special report: Looking for the psychosocial impacts of genomic information. In., vol. 49 Hastings Cent Rep; 2019: S2– S96. 31268574 PMC6640636
  2. [2]Ryan KA, De Vries RG, Uhlmann WR, Roberts JS, Gornick MC: Public’s Views toward Return of Secondary Results in Genomic Sequencing: It’s (Almost) All about the Choice. Journal of genetic counseling 2017, 26(6): 1197– 1212. 28357777 PMC5620108
  3. [3]Kaufman DJ, Baker R, Milner LC, Devaney S, Hudson KL: A survey of U.S adults’ opinions about conduct of a nationwide Precision Medicine Initiative(R) Cohort Study of genes and environment. PLoS One 2016, 11(8): e0160461. PMC4988644 27532667
  4. [4]O’Daniel J, Haga SB: Public perspectives on returning genetics and genomics research results. Public health genomics 2011, 14(6): 346– 355. 21555865 PMC3221258
  5. [5]Yu JH, Harrell TM, Jamal SM, Tabor HK, Bamshad MJ: Attitudes of genetics professionals toward the return of incidental results from exome and whole-genome sequencing. Am J Hum Genet 2014, 95(1): 77– 84. 24975944 PMC4085580
  6. [6]Stein CM, Ponsaran R, Trapl ES, Goldenberg AJ: Experiences and perspectives on the return of secondary findings among genetic epidemiologists. Genet Med 2019, 21(7): 1541– 1547. 30467403
  7. [7]Klitzman R, Appelbaum PS, Fyer A, Martinez J, Buquez B, Wynn J, Waldman CR, Phelan J, Parens E, Chung WK: Researchers’ views on return of incidental genomic research results: qualitative and quantitative findings. Genet Med 2013, 15(11): 888– 895. 23807616 PMC3823712
  8. [8]Strong KA, Zusevics KL, Bick DP, Veith R: Views of nonmedical, health system professionals regarding the return of whole genome sequencing incidental findings. WMJ 2014, 113(5): 179– 184. 25739160
  9. [9]Wynn J, Martinez J, Duong J, Chiuzan C, Phelan JC, Fyer A, Klitzman RL, Appelbaum PS, Chung WK: Research Participants’ Preferences for Hypothetical Secondary Results from Genomic Research. Journal of genetic counseling 2017, 26(4): 841– 851. 28035592
  10. [10]Allen NL, Karlson EW, Malspeis S, Lu B, Seidman CE, Lehmann LS: Biobank participants’ preferences for disclosure of genetic research results: perspectives from the OurGenes, OurHealth, OurCommunity project. Mayo Clin Proc 2014, 89(6): 738– 746. 24943692 PMC4148696
  11. [11]Murphy J, Scott J, Kaufman D, Geller G, LeRoy L, Hudson K: Public expectations for return of results from large-cohort genetic research. The American journal of bioethics: AJOB 2008, 8(11): 36– 43. PMC2682364 19061108
  12. [13]Denny JC, Rutter JL, Goldstein DB, Philippakis A, Smoller JW, Jenkins G, Dishman E: The “All of Us” Research Program. N Engl J Med 2019, 381(7): 668– 676. 31412182 PMC8291101
  13. [14]d’Agincourt-Canning L, Baird P: Genetic testing for hereditary cancers: the impact of gender on interest, uptake and ethical considerations. Crit Rev Oncol Hematol 2006, 58(2): 114– 123. 16600617
  14. [15]Yu JH, Crouch J, Jamal SM, Tabor HK, Bamshad MJ: Attitudes of African Americans toward return of results from exome and whole genome sequencing. Am J Med Genet A 2013, 161a(5): 1064– 1072. 23610051 PMC3635144
  15. [16]Fiallos K, Applegate C, Mathews DJ, Bollinger J, Bergner AL, James CA: Choices for return of primary and secondary genomic research results of 790 members of families with Mendelian disease. Eur J Hum Genet 2017, 25(5): 530– 537. 28272539 PMC5437901
  16. [17]Wilkins CH, Mapes BM, Jerome RN, Villalta-Gil V, Pulley JM, Harris PA: Understanding What Information Is Valued By Research Participants, And Why. Health Aff (Millwood) 2019, 38(3): 399– 407. 30830824 PMC6706772
  17. [19]Sabatello M, Schulze M (eds.): Human Rights and Disability Advocacy Philadelphia: University of Pennsylvania Press; 2014.
  18. [20]Nelson Schmitt SS, Leigh IW: Examining a sample of Black deaf individuals on the Deaf Acculturation Scale. Journal of deaf studies and deaf education 2015, 20(3): 283– 295. 25967584
  19. [21]Bong C, Potrata B, Hewison J, McKibbin M: Attitudes of patients and relatives/carers towards genetic testing for inherited retinal disease. Eye 2010, 24(10): 1622– 1625. 20577274
  20. [22]Blankmeyer Burke T, Snoddon K, Wilkinson E: Genetics and Deafness: a view from the inside In: Genetics of Deafness Edited by Vona B, Haaf T. Basel: Karger; 2016: 1– 8.
  21. [23]Baron-Cohen S: Editorial Perspective: Neurodiversity - a revolutionary concept for autism and psychiatry. J Child Psychol Psychiatry 2017, 58(6): 744– 747. 28524462
  22. [24]Collins FS, Varmus H: A new initiative on precision medicine. N Engl J Med 2015, 372(9): 793– 795. 25635347 PMC5101938
  23. [25]Chen JJ, Lu TP, Chen YC, Lin WJ: Predictive biomarkers for treatment selection: statistical considerations. Biomark Med 2015, 9(11): 1121– 1135. 26507127
  24. [26]Ginsburg GS, Phillips KA: Precision Medicine: From Science To Value. Health Aff (Millwood) 2018, 37(5): 694– 701. 29733705 PMC5989714
  25. [28]Thorogood A, Dalpe G, Knoppers BM: Return of individual genomic research results: are laws and policies keeping step? Eur J Hum Genet 2019, 27(4): 535– 546. 30622328 PMC6460582
  26. [29]Crawford DC, Cooke Bailey JN, Briggs FBS: Mind the gap: resources required to receive, process and interpret research-returned whole genome data. Hum Genet 2019, 138(7): 691– 701. 31161416 PMC6767905
  27. [30]Sanderson SC, Linderman MD, Suckiel SA, Diaz GA, Zinberg RE, Ferryman K, Wasserstein M, Kasarskis A, Schadt EE: Motivations, concerns and preferences of personal genome sequencing research participants: Baseline findings from the HealthSeq project. Eur J Hum Genet 2016, 24(1): 14– 20. 26036856 PMC4795230
  28. [31]Bentley AR, Callier S, Rotimi CN: Diversity and inclusion in genomic research: why the uneven progress? Journal of community genetics 2017, 8(4):255–266. PMC5614884 28770442
  29. [32]Halbert CH, McDonald J, Vadaparampil S, Rice L, Jefferson M: Conducting precision medicine research with african americans. PLoS One 2016, 11(7): e0154850. PMC4956119 27441706
  30. [34]Sohn H: Racial and ethnic disparities in health insurance coverage: Dynamics of gaining and losing coverage over the life-course. Population research and policy review 2017, 36(2): 181– 201. 28366968 PMC5370590
  31. [35]King PA: Race, justice and research In: Beyond consent: Seeking justice in Research Edited by Kahn JP, Mastroianni AC. Oxford; NY: Oxford Univeristy Press; 1998: 88– 110.
  32. [36]Garrison NA: Genomic Justice for Native Americans: Impact of the Havasupai Case on Genetic Research. Science, technology & human values 2013, 38(2): 201– 223. PMC5310710 28216801
  33. [37]Kaphingst KA, Ivanovich J, Lyons S, Biesecker B, Dresser R, Elrick A, Matsen C, Goodman M: Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factors. Transl Behav Med 2018, 8(1): 71– 79. 29385583 PMC6065546
  34. [38]Palmer CG, Boudreault P, Berman BA, Wolfson A, Duarte L, Venne VL, Sinsheimer JS: Bilingual approach to online cancer genetics education for Deaf American Sign Language users produces greater knowledge and confidence than English text only: A randomized study. Disability and health journal 2017, 10(1): 23– 32. 27594054 PMC5136526
  35. [40]Sabatello M, Chen Y, Zhang Y, Appelbaum PS: Disability inclusion in precision medicine research: a first national survey. Genet Med 2019. PMC6755064 30899094
  36. [41]Silverman A: Healing the blind: perspectives of blind persons on methods to restore sight. In: Nanotechnology, the brain and the future Edited by Scott Robert J, Miller CA, Hays SA, Bennett I. Netherlands: Springer; 2013: 159– 166.
  37. [42]Boudreault P, Baldwin EE, Fox M, Dutton L, Tullis L, Linden J, Kobayashi Y, Zhou J, Sinsheimer JS, Sininger Y: Deaf adults’ reasons for genetic testing depend on cultural affiliation: results from a prospective, longitudinal genetic counseling and testing study. Journal of deaf studies and deaf education 2010, 15(3): 209– 227. 20488870 PMC2902357
  38. [43]Kapp SK, Gillespie-Lynch K, Sherman LE, Hutman T: Deficit, difference, or both? Autism and neurodiversity. Dev Psychol 2013, 49(1): 59– 71. 22545843
  39. [44]Williams AS, Moore SM: Universal design of research: inclusion of persons with disabilities in mainstream biomedical studies. Sci Transl Med 2011, 3(82): 82cm12. PMC3320239 21562227
  40. [45]Rios D, Magasi S, Novak C, Harniss M: Conducting accessible research: Including people with disabilities in public health, epidemiological, and outcomes studies. Am J Public Health 2016, 106(12): 2137– 2144. 27736212 PMC5104996
  41. [46]Sarfati D, Koczwara B, Jackson C: The impact of comorbidity on cancer and its treatment. CA Cancer J Clin 2016, 66(4): 337– 350. 26891458
  42. [47]McDonald KE, Keys CB: How the powerful decide: access to research participation by those at the margins. Am J Community Psychol 2008, 42(1–2): 79– 93. 18584318
  43. [48]Scherr CL, Ramesh S, Marshall-Fricker C, Perera MA: A Review of African Americans’ Beliefs and Attitudes About Genomic Studies: Opportunities for Message Design. Frontiers in genetics 2019, 10(548). PMC6587098 31258547
  44. [49]Sabatello M: Precision medicine, health disparities, and ethics: the case for disability inclusion. Genet Med 2018, 20(4): 397– 399. 28771252 PMC5797520
  45. [51]Kraft SA, Cho MK, Gillespie K, Halley M, Varsava N, Ormond KE, Luft HS, Wilfond BS, Soo-Jin Lee S: Beyond consent: Building trusting relationships with diverse populations in precision medicine research. The American journal of bioethics: AJOB 2018, 18(4): 3– 20. PMC6173191 29621457
  46. [52]Sabatello M: Cultivating inclusivity in precision medicine research: disability, diversity, and cultural competence. Journal of community genetics 2019, 10(3): 363– 373. 30539340 PMC6591334

Cited by

Sorted by citations

Authors
Sabatello, M., Zhang, Y., Chen, Y., & Appelbaum, P. S.
Affiliations
  • Columbia University Irving Medical Center (US)
  • Columbia University (US)
  • New York State Psychiatric Institute (US)
Venue
Public Health Genomics
Publisher
S. Karger AG
Published
2020
Volume
23
Issue
1-2
Pages
42-53
ISSN
  • 1422-2795 (ISSN-L)
  • 1662-4246
  • 1662-8063
OpenAlex
W3015990120
Cited by
25
References
4
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 1
FWCI
3.00
Type
journal article
Language
en
Open access
Locations
  • Public Health Genomics (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Human Genome Research Institute (K01HG008653, P50HG007257, RM1HG007257)
  • NIH Office of the Director (3P50HG007257-05S1)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Race, Genetics, and Society
  • Health Sciences › Medicine › Physiology › Biomedical Ethics and Regulation
Keywords
return of results, people with disabilities, research participant perspectives, translational research, underrepresented groups, research participation
MeSH terms
Adult, Female, Disabled Persons, Persons with Disabilities, Humans, Male, Social Perception, Research Subjects, Genetic Research, Information Seeking Behavior, Precision Medicine, Social Marginalization, Medicalization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review